Article
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression - Nature Biomedical Engineering
Rating:
0.0
Views:
21
Likes:
1
Library:
1
Allogeneic mesenchymal stromal cells (MSCs) are a safe treatment option for many disorders of the immune system. However, clinical trials using MSCs have shown inconsistent therapeutic efficacy, mostly owing to MSCs providing insufficient immunosuppression in target tissues.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value